AVIXAA Cutting-Edge Aesthetic Technologies are developed to solve the fundamental biological barrier in medical aesthetics: achieving deep dermal active bioavailability without traumatic thermal injury or prolonged downtime.
The AVIXAA Precision Dermal Active Delivery Platform pairs targeted micro-channeling with pulsed low-voltage electroporation, allowing macromolecular actives such as high-molecular hyaluronic acid, PDRN, and bio-peptides to penetrate directly to the basal membrane and reticular dermis with surgical accuracy.
Technological Innovations & Clinical Precision
- Ultra-Precise Microneedle Penetration: Stepper-motor controlled penetration calibrated in 0.1mm increments from 0.2mm to 2.5mm prevents uneven tissue tearing and micro-hemorrhage.
- Synergistic Electro-Permeabilization: Creates transient hydrophilic pores in lipid bi-layers, increasing active compound uptake by up to 400% compared to topical application alone.
- Pre-Set Clinical Indication Modes: Dedicated pre-calibrated physician modes for acne scarring, skin laxity, periorbital rejuvenation, and scalp follicular stimulation.
- Single-Use Sterile Cartridge Safety: Zero backflow design and anti-cross-contamination locking mechanism assuring absolute patient safety.
All equipment is accompanied by comprehensive biomedical engineering support, certified physician training modules, and warranty service across India.
Clinical Case Study & Active Absorption
Fluorescence imaging confirms deep reticular dermal penetration of peptide actives when delivered via the AVIXAA Platform:
